Oxetan-3-ylmethyl 4-methylbenzene-1-sulfonate → 1-(6-(1,4-Diazepan-1-yl)pyridin-2-yl)-6-(1-(oxetan-3-ylmethyl)-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-c]pyridine

HRID 57860Notes

Reaction equation

HRID 57860 reaction equation
[NH:1]1[CH:5]=[C:4]([C:6]2[N:11]=[CH:10][C:9]3[CH:12]=[N:13][N:14]([C:15]4[N:20]=[C:19]([N:21]5[CH2:27][CH2:26][CH2:25][N:24](C(OC(C)(C)C)=O)[CH2:23][CH2:22]5)[CH:18]=[CH:17][CH:16]=4)[C:8]=3[CH:7]=2)[CH:3]=[N:2]1.CC1C=CC(S(O[CH2:46][CH:47]2[CH2:50][O:49][CH2:48]2)(=O)=O)=CC=1>>[N:21]1([C:19]2[N:20]=[C:15]([N:14]3[C:8]4[CH:7]=[C:6]([C:4]5[CH:3]=[N:2][N:1]([CH2:46][CH:47]6[CH2:50][O:49][CH2:48]6)[CH:5]=5)[N:11]=[CH:10][C:9]=4[CH:12]=[N:13]3)[CH:16]=[CH:17][CH:18]=2)[CH2:27][CH2:26][CH2:25][NH:24][CH2:23][CH2:22]1

Participants

3

Procedure

Following the procedures as described in Example 61 and starting with tert-butyl 4-(6-(6-(1H-pyrazol-4-yl)-1H-pyrazolo[4,3-c]pyridin-1-yl)pyridin-2-yl)-1,4-diazepane-1-carboxylate and oxetan-3-ylmethyl 4-methylbenzenesulfonate, 158 was obtained as a yellow solid (38 mg, 51%) over two steps. 1H-NMR (500 MHz, CD3OD) δ (ppm): 9.16-9.19 (m, 1H), 8.86-8.77 (m, 3H), 8.43-8.47 (m, 1H), 7.66-7.73 (m, 1H), 7.18-7.26 (m, 1H), 6.63-6.66 (m, 1H), 4.81-4.83 (m, 2H), 4.60-4.64 (m, 2H), 3.75-3.97 (m, 7H), 3.61-3.64 (m, 1H), 3.46-3.48 (m, 1H), 3.10-3.12 (m, 1H), 2.88-2.90 (m, 1H), 1.98-2.07 (m, 2H); MS (ESI) m/z: 431 [M+H]+.

Sources & evidence

ORD record
ord-9540c08f15824de0a24b0ceb494f4bd5
Source dataset
uspto-grants-2016_09
Patent number
US09434725B2

Reaction notes

Loading…